Literature DB >> 22797451

Rates of treated and untreated kidney failure in older vs younger adults.

Brenda R Hemmelgarn1, Matthew T James, Braden J Manns, Ann M O'Hare, Paul Muntner, Pietro Ravani, Robert R Quinn, Tanvir Chowdhury Turin, Zhi Tan, Marcello Tonelli.   

Abstract

CONTEXT: Studies of kidney failure in older adults have focused on receipt of dialysis, which may underestimate the burden of disease if older people are less likely to receive treatment.
OBJECTIVE: To determine the extent to which age is associated with the likelihood of treatment of kidney failure. DESIGN, SETTING, AND PARTICIPANTS: Community-based cohort study of 1,816,824 adults in Alberta, Canada, who had outpatient estimated glomerular filtration rate (eGFR) measured between May 1, 2002, and March 31, 2008, with a baseline eGFR of 15 mL/min/1.73 m2 or higher and who did not require renal replacement therapy at baseline. Age was categorized as 18 to 44, 45 to 54, 55 to 64, 65 to 74, 75 to 84, and 85 or more years and eGFR as 90 or higher, 60 to 89, 45 to 59, 30 to 44, and 15 to 29 mL/min/1.73 m2. MAIN OUTCOME MEASURES: Adjusted rates of treated kidney failure (receipt of dialysis or kidney transplantation), untreated kidney failure (progression to eGFR <15 mL/min/1.73 m2 without renal replacement therapy), and death.
RESULTS: During a median follow-up of 4.4 years, 97,451 (5.36%) died, 3295 (0.18%) developed kidney failure that was treated and 3116 (0.17%) developed kidney failure that went untreated. Within each eGFR stratum the rate of treated kidney failure was higher in younger compared with older people. For example, in the lowest eGFR stratum (15-29 mL/min/1.73 m2), adjusted rates of treated kidney failure were more than 10-fold higher among the youngest (18-44 years) compared with the oldest (≥85 years) groups (adjusted rate, 24.00 [95% CI, 14.78-38.97] vs 1.53 [95% CI, 0.59-3.99] per 1000 person-years, respectively; P < .001). Rates of untreated kidney failure were consistently higher at older ages. In the eGFR stratum of 15 to 29 mL/min/1.73 m2, adjusted rates of untreated kidney failure were more than 5-fold higher among the oldest (≥85 years), compared with the youngest (18-44 years) groups (adjusted rate, 19.95 [95% CI, 15.79-25.19] vs 3.53 [95% CI, 1.56-8.01] per 1000 person-years, respectively; P < .001). Rates of kidney failure overall (treated and untreated combined) demonstrated less variation across age groups; eg, the adjusted rate per 1000 person years for those with eGFR of 15-29 mL/min/1.73 m2 was 36.45 (95% CI, 24.46-54.32) among participants aged 18 to 44 years and 20.19 (95% CI, 15.27-26.69) among those aged 85 years or older (P = .01).
CONCLUSION: In Alberta, Canada, rates of untreated kidney failure are significantly higher in older compared with younger individuals.

Entities:  

Mesh:

Year:  2012        PMID: 22797451     DOI: 10.1001/jama.2012.6455

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  51 in total

1.  Predialysis health, dialysis timing, and outcomes among older United States adults.

Authors:  Deidra C Crews; Julia J Scialla; Jiannong Liu; Haifeng Guo; Karen Bandeen-Roche; Patti L Ephraim; Bernard G Jaar; Stephen M Sozio; Dana C Miskulin; Navdeep Tangri; Tariq Shafi; Klemens B Meyer; Albert W Wu; Neil R Powe; L Ebony Boulware
Journal:  J Am Soc Nephrol       Date:  2013-10-24       Impact factor: 10.121

Review 2.  Caring for patients with kidney disease: shifting the paradigm from evidence-based medicine to patient-centered care.

Authors:  Ann M O'Hare; Rudolph A Rodriguez; Christopher Barrett Bowling
Journal:  Nephrol Dial Transplant       Date:  2015-01-29       Impact factor: 5.992

3.  Lifetime risk of ESRD: a meaningful concept?

Authors:  Paul Eggers
Journal:  J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 10.121

4.  Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.

Authors:  Navdeep Tangri; Morgan E Grams; Andrew S Levey; Josef Coresh; Lawrence J Appel; Brad C Astor; Gabriel Chodick; Allan J Collins; Ognjenka Djurdjev; C Raina Elley; Marie Evans; Amit X Garg; Stein I Hallan; Lesley A Inker; Sadayoshi Ito; Sun Ha Jee; Csaba P Kovesdy; Florian Kronenberg; Hiddo J Lambers Heerspink; Angharad Marks; Girish N Nadkarni; Sankar D Navaneethan; Robert G Nelson; Stephanie Titze; Mark J Sarnak; Benedicte Stengel; Mark Woodward; Kunitoshi Iseki
Journal:  JAMA       Date:  2016-01-12       Impact factor: 56.272

Review 5.  Chronic kidney disease and the aging population.

Authors:  Marcello Tonelli; Miguel Riella
Journal:  J Nephrol       Date:  2014-02       Impact factor: 3.902

6.  Chronic kidney disease and the aging population.

Authors:  Marcello Tonelli; Miguel Riella
Journal:  J Cross Cult Gerontol       Date:  2014-06

7.  Chronic kidney disease in the elderly: evaluation and management.

Authors:  Mary Mallappallil; Eli A Friedman; Barbara G Delano; Samy I McFarlane; Moro O Salifu
Journal:  Clin Pract (Lond)       Date:  2014

8.  Decisions about Renal Replacement Therapy in Patients with Advanced Kidney Disease in the US Department of Veterans Affairs, 2000-2011.

Authors:  Susan P Y Wong; Paul L Hebert; Ryan J Laundry; Kenric W Hammond; Chuan-Fen Liu; Nilka R Burrows; Ann M O'Hare
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-22       Impact factor: 8.237

9.  A simple tool to predict end-stage renal disease within 1 year in elderly adults with advanced chronic kidney disease.

Authors:  Paul E Drawz; Puja Goswami; Reem Azem; Denise C Babineau; Mahboob Rahman
Journal:  J Am Geriatr Soc       Date:  2013-04-25       Impact factor: 5.562

10.  Acute Kidney Injury and Subsequent Frailty Status in Survivors of Critical Illness: A Secondary Analysis.

Authors:  Khaled Abdel-Kader; Timothy D Girard; Nathan E Brummel; Christina T Saunders; Jeffrey D Blume; Amanda J Clark; Andrew J Vincz; E Wesley Ely; James C Jackson; Susan P Bell; Kristin R Archer; T Alp Ikizler; Pratik P Pandharipande; Edward D Siew
Journal:  Crit Care Med       Date:  2018-05       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.